All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

8

Reset

8 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • SHR-1918Phase 37 trials

    Beijing Suncadia Pharmaceuticals Co., Ltd · Homozygous Familial Hypercholesterolemia, Hyperlipidemia, Hypercholesterolemia

  • QLC7401Phase 34 trials

    Qilu Pharmaceutical Co., Ltd. · Primary Hypercholesterolemia or Mixed Hyperlipidemia, Heterozygous Familial Hypercholesterolemia (HeFH)

  • SYH2053Phase 34 trials

    CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · Non-familial Hypercholesterolemia and Mixed Hyperlipidemia, Heterozygous Familial Hypercholesterolemia (HeFH), Hypercholesterolemia and Mixed Hyperlipidemia

  • SAL003Phase 32 trials

    Shenzhen Salubris Pharmaceuticals Co., Ltd. · Hyperlipidemias, Hypercholesterolemia, Mixed Dyslipidemia, Hyperlipidemias

  • IBI306Phase 31 trial

    Innovent Biologics (Suzhou) Co. Ltd. · Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia

  • HRS-7249Phase 22 trials

    Fujian Shengdi Pharmaceutical Co., Ltd. · Hyperlipidemia

  • HRS-1301Phase 21 trial

    Shandong Suncadia Medicine Co., Ltd. · Hyperlipidemia

  • SYH2070Phase 21 trial

    CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · Mixed Hyperlipidemia

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.